Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
Aviva Canada Selects Mitchell Solutions to Help Streamline Claims Management
SAN DIEGO, Calif.— Mitchell, an Enlyte company and leading technology and information provider for the Property and Casualty (P&C) claims and Collision Repair industries, today announced that Aviva Canada has implemented its full suite of enterprise claims management solutions.
Unlocking the DME “Black Box”
CDC Updates and Replaces Guidelines for Prescribing Opioids
The Centers for Disease Control and Prevention (CDC) released an updated and expanded recommendation for clinicians prescribing opioids for outpati
The Impact of Resilience on Recovery from Injury or Illness
A key component of resilience is optimism, a hopeful, positive outlook on the future and the world around us.
Ask The Pharmacist: Traveling With a Controlled Substance Prescription Medication
Are there rules or recommendations for traveling with a controlled substance?
Trends in Third Party Claims and How to Address Them
In this podcast, Norman Tyrell, vice president of product management for Mitchell Casualty Solutions Group, discusses major trends in third party claims and how they’re impacting our industry